Home > Insider Trading > Filing (0000904454-11-000667)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1382911	Orexigen Therapeutics Inc.	OREX	Pharmaceutical Preparations (2834)	651178822

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1354718	K Brian Halak	C/O Domain Associates, Llc One Palmer Square Princeton NJ 08542		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-12-22	461,265	$1.45	2,967,415	No	4	P	Indirect	By Domain Partners VII, L.P.
Common Stock	Acquisiton	2011-12-22	7,882	$1.45	50,643	No	4	P	Indirect	By DP VII Associates, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Domain Partners VII, L.P.
No	4	P	Indirect	By DP VII Associates, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-12-22	461,265	$14.49	4,612,650	$0.00
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2011-12-22	7,882	$14.49	78,820	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
461,265	2011-12-22	2021-12-22	No	4	P	Indirect
7,882	2011-12-22	2021-12-22	No	4	P	Indirect

Footnotes

The Common Stock and Warrants were sold as units at a purchase price of $15.94 per unit, each unit consisting of one share of Common Stock and one Warrant to purchase ten shares of Common Stock.
The Reporting Person is a Managing Member of One Palmer Square Associates VII, LLC, which is the sole general partner of Domain Partners VII, L.P. and DP VII Associates, L.P. Pursuant to Instruction 4(b)(iv) ofForm 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities,and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
The Reporting Person also directly beneficially owns 4,529 shares of Common Stock and indirectly beneficially owns 1,963 shares held by Domain Associates, LLC. The Reporting Person is a Managing Member of Domain Associates, LLC. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securitiesbeneficially owned by such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributedto him or her.